Gainers & Losers
Wed Jan 14 2026 10:28:00- Tata Steel share price
- ₹189.253.70%
- NTPC share price
- ₹348.953.29%
- AXIS Bank Ltd share price
- ₹1,299.552.98%
- UltraTech Cement share price
- ₹12,235.001.65%
- Eternal share price
- ₹299.201.60%
Active Stocks
Wed Jan 14 2026 10:25:45- Yes Bank share price
- ₹22.950.70%
- Gail (India) share price
- ₹165.20-0.06%
- Suzlon Energy share price
- ₹49.010.62%
- Tata Steel share price
- ₹189.253.70%
- Vedanta share price
- ₹675.706.06%
Business News/Market/Market Stats/Jubilant Pharmova share price/ Jubilant Pharmova Profit Loss Annual
Jubilant Pharmova Profit & Loss Annual
1,066.60 +26.40 (2.54%)Updated : 14 Jan 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 6,068.20 | 6,348.70 | 6,108.72 | 5,305.71 |
| Other Net | 0.20 | -0.50 | -8.32 | 1.44 |
| Diluted Weighted Average Shares | 15.89 | 15.89 | 15.91 | 15.92 |
| Depreciation/ Amortization | 368.60 | 381.90 | 382.60 | 381.70 |
| Operating Income | 1,166.30 | 354.20 | 173.01 | 824.45 |
| Net Income | 839.40 | 77.10 | -60.98 | 413.94 |
| Income Availableto Com Excl Extra Ord | 839.40 | 77.10 | -60.98 | 413.94 |
| Other Operating Expenses Total | 52.00 | 57.80 | 56.03 | 29.93 |
| Net Income Before Taxes | 980.60 | 170.50 | 27.78 | 630.45 |
| Minority Interest | 3.10 | 4.40 | 3.90 | 0.92 |
| Net Income After Taxes | 836.30 | 72.70 | -64.88 | 413.02 |
| Income Availableto Com Incl Extra Ord | 839.40 | 77.10 | -60.98 | 413.94 |
| Costof Revenue Total | 2,765.90 | 2,571.00 | 2,389.50 | 1,921.29 |
| Gross Profit | 4,468.60 | 4,131.90 | 3,892.23 | 4,208.88 |
| Interest Inc( Exp) Net- Non- Op Total | -185.90 | -183.20 | -134.25 | -192.08 |
| Unusual Expense( Income) | -359.50 | 168.90 | 228.24 | 0.00 |
| Diluted Net Income | 839.40 | 77.10 | -60.98 | 413.94 |
| DPS- Common Stock Primary Issue | 5.00 | 5.00 | 5.00 | 5.00 |
| Provisionfor Income Taxes | 144.30 | 97.80 | 92.66 | 217.43 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 839.40 | 77.10 | -60.98 | 413.94 |
| Total Revenue | 7,234.50 | 6,702.90 | 6,281.73 | 6,130.16 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 7,234.50 | 6,702.90 | 6,281.73 | 6,130.16 |
| Selling/ General/ Admin Expenses Total | 3,241.20 | 3,169.10 | 3,052.34 | 2,972.79 |
| Diluted Normalized EPS | 33.54 | 9.39 | 5.60 | 26.14 |
| Diluted EPS Excluding Extra Ord Items | 52.84 | 4.85 | -3.83 | 26.01 |
| Gain( Loss)on Saleof Assets | - | - | -2.66 | -3.37 |
| Total Extraordinary Items | - | - | - | 0.00 |
*All figures in crores except per share values
Jubilant Pharmova Quick Links
Jubilant Pharmova Dividend Jubilant Pharmova Bonus Jubilant Pharmova News Jubilant Pharmova AGM Jubilant Pharmova Rights Jubilant Pharmova Splits Jubilant Pharmova Board Meetings Jubilant Pharmova Key Metrics Jubilant Pharmova Shareholdings Jubilant Pharmova Balance Sheet Jubilant Pharmova Cashflow Jubilant Pharmova Q1 Results Jubilant Pharmova Q2 Results Jubilant Pharmova Q3 Results Jubilant Pharmova Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
189.25+6.75(3.70%)
348.95+11.10(3.29%)
1,299.55+37.65(2.98%)
2,815.35-69.00 (-2.39%)
3,192.30-75.30 (-2.30%)